abstract |
The invention relates to compounds of formula (I), in which the groups R1, M, A, B, D, L and R are defined as cited in the description, and to their physiologically compatible salts. The compounds are suitable e.g. for treating metabolic syndrome, insulin resistance, obesity and diabetes. |